PRESS RELEASE published on 05/15/2025 at 17:45, 8 months 17 days ago Affluent Medical announces promising performance results for its Artus artificial urinary sphincter and receives approval to initiate pivotal phase of its clinical trial Affluent Medical announces promising performance results for its Artus artificial urinary sphincter and approval for pivotal clinical trial phase to reduce urinary leakage by 87% Affluent Medical Clinical Trial Artus Urinary Sphincter Urinary Leakage
BRIEF published on 05/02/2025 at 17:50, 8 months 30 days ago Availability of the 2024 Universal Registration Document by Affluent Medical Financial Markets Authority Financial Report Affluent Medical 2024 Registration Document Medical Prosthetics
BRIEF published on 04/24/2025 at 17:50, 9 months 7 days ago Affluent Medical achieves major progress in 2024 Clinical Development Affluent Medical Cardiology Medical Innovation Strategic Agreements
PRESS RELEASE published on 04/24/2025 at 17:45, 9 months 7 days ago Affluent Medical : 2024 FULL YEAR RESULTS Affluent Medical reached major new milestones in executing its clinical roadmap Affluent Medical reached major new milestones in executing its clinical roadmap in 2024, including transformative agreements and positive FDA feedback. Financial results show progress and strategic appointments Financial Results Affluent Medical FDA Feedback Milestones 2024 Full Year Results
PRESS RELEASE published on 04/24/2025 at 17:45, 9 months 7 days ago 2024 FULL YEAR RESULTS Affluent Medical reached major new milestones in executing its clinical roadmap Affluent Medical announces major milestones in its 2024 full-year results including transformative agreements, regulatory validations, and clinical advancements, positioning the company for market launch Medical Technology Affluent Medical Clinical Advancements Market Launch 2024 Full-year Results
BRIEF published on 04/15/2025 at 17:50, 9 months 16 days ago Affluent Medical Advances Towards SPHINX Study for Female SUI Treatment Affluent Medical Artus Device SPHINX Study Female Stress Incontinence Minimally Invasive
PRESS RELEASE published on 04/15/2025 at 17:45, 9 months 16 days ago Affluent Medical Announces Progress Toward European Clinical Study of Artificial Sphincter Artus for the Treatment of Urinary Stress Incontinence in Women. Affluent Medical progresses towards European clinical study of Artificial Sphincter Artus for treating Urinary Stress Incontinence in Women. The upcoming SPHINX study will assess device safety and performance Affluent Medical Women European Clinical Study Artificial Sphincter Artus Urinary Stress Incontinence
PRESS RELEASE published on 04/15/2025 at 17:45, 9 months 16 days ago Affluent Medical Announces Progress Toward European Clinical Study of Artificial Sphincter Artus for the Treatment of Urinary Stress Incontinence in Women Affluent Medical progresses towards European clinical study of Artus artificial sphincter for treating urinary stress incontinence in women. Minimally invasive procedure feasibility confirmed Affluent Medical Women Artus European Clinical Study Urinary Stress Incontinence
BRIEF published on 04/11/2025 at 17:45, 9 months 20 days ago Update of Affluent Medical's capital and voting rights Euronext Paris Share Capital Voting Rights AMF Affluent Medical
BRIEF published on 03/11/2025 at 17:50, 10 months 21 days ago Affluent Medical Appoints New Leaders to Advance Medical Innovations Innovation Medical Devices Clinical Trials Affluent Medical Leadership Appointments
Published on 02/02/2026 at 15:00, 55 minutes ago Jericho Energy Ventures Strategically Terminates SmartKem LOI to Advance Independent Data Center Energy Infrastructure Platform
Published on 02/02/2026 at 14:30, 1 hour 25 minutes ago Unusual Machines Promotes Drew Camden to President
Published on 02/02/2026 at 14:30, 1 hour 25 minutes ago Predictiv AI Provides Pilot Update from Innovate Calgary's Soaring Higher Challenge with Calgary Airports and WestJet
Published on 02/02/2026 at 14:30, 1 hour 25 minutes ago NanoViricides President Dr. Diwan Interviewed by Mission Matters' Adam Torres
Published on 02/02/2026 at 14:00, 1 hour 55 minutes ago Paymetrex Launches Patent Licensing Program to Monetize Mobile Payments IP Portfolio
Published on 02/02/2026 at 15:36, 18 minutes ago Successful Refinancing: CHEPLAPHARM'S new 6.750% Bond multiple times oversubscribed
Published on 02/02/2026 at 15:08, 46 minutes ago EQS-Adhoc: Resignation of the Chairman of the Supervisory Board
Published on 02/02/2026 at 15:00, 55 minutes ago GURIT EARNS ECOVADIS GOLD MEDAL FOR SUSTAINABILITY EXCELLENCE FOR THE THIRD CONSECUTIVE YEAR
Published on 02/02/2026 at 14:51, 1 hour 3 minutes ago Aroundtown SA: Release of a capital market information
Published on 02/02/2026 at 14:35, 1 hour 20 minutes ago Newmark Engaged by Vornado Realty Trust for Next Phase of THE PENN DISTRICT Retail Renaissance
Published on 01/30/2026 at 17:45, 2 days 22 hours ago Schneider Electric launches a capital increase reserved for employees
Published on 01/29/2026 at 18:00, 3 days 21 hours ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 3 days 22 hours ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE